- Filed
- Jun 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Jun 3, 2026 | 35.63M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2026 | 35.69M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2026 | 35.81M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2025 | 37.28M sh |
| Shares Diluted | Q3 2026 · Apr 30, 2025 | 37.41M sh |
| Stock Repurchased | Q3 2026 · Apr 30, 2026 | $45M |
| Stock Repurchased | Q3 2026 · Apr 30, 2025 | $30M |
| Stock Repurchased | Q3 2026 · Apr 30, 2025 | $70M |
| Dividends Paid | Q3 2026 · Apr 30, 2026 | $238.02M |
| Dividends Paid | Q3 2026 · Apr 30, 2025 | $248.46M |
| Capex | Q3 2026 · Apr 30, 2026 | $181.64M |
| Capex | Q3 2026 · Apr 30, 2025 | $179.25M |
| Operating Cash Flow | Q3 2026 · Apr 30, 2026 | $582.67M |
| Operating Cash Flow restated | Q3 2026 · Apr 30, 2025 | $724.6M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2026 | $371.37M |
| Cash And Equivalents | Q3 2026 · Jul 31, 2025 | $440.29M |
| Cash And Equivalents | Q3 2026 · Apr 30, 2025 | $467.03M |
| Stockholders Equity | Q3 2026 · Apr 30, 2026 | $551.73M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $424.5M |
| Stockholders Equity restated | Q3 2026 · Apr 30, 2025 | $877.17M |
| Current Liabilities | Q3 2026 · Apr 30, 2026 | $1.04B |
| Current Liabilities | Q3 2026 · Jul 31, 2025 | $1.67B |
| Current Liabilities restated | Q3 2026 · Apr 30, 2025 | $1.63B |
| Total Liabilities | Q3 2026 · Apr 30, 2026 | $4.77B |
| Total Liabilities | Q3 2026 · Jul 31, 2025 | $5.02B |
| Total Liabilities restated | Q3 2026 · Apr 30, 2025 | $4.53B |
| Current Assets | Q3 2026 · Apr 30, 2026 | $952.22M |
| Current Assets | Q3 2026 · Jul 31, 2025 | $1.05B |
| Current Assets restated | Q3 2026 · Apr 30, 2025 | $999.41M |
| Total Assets | Q3 2026 · Apr 30, 2026 | $5.69B |
| Total Assets | Q3 2026 · Jul 31, 2025 | $5.78B |
| Total Assets restated | Q3 2026 · Apr 30, 2025 | $5.75B |
| Eps Diluted | Q3 2026 · Apr 30, 2026 | $8.81 |
| Eps Diluted | Q3 2026 · Apr 30, 2026 | $9.43 |
| Eps Diluted restated | Q3 2026 · Apr 30, 2025 | $10.46 |
| Eps Diluted restated | Q3 2026 · Apr 30, 2025 | $12.32 |
| Eps Basic | Q3 2026 · Apr 30, 2026 | $8.82 |
| Eps Basic | Q3 2026 · Apr 30, 2026 | $9.44 |
| Eps Basic restated | Q3 2026 · Apr 30, 2025 | $10.47 |
| Eps Basic restated | Q3 2026 · Apr 30, 2025 | $12.33 |
| Net Income | Q3 2026 · Apr 30, 2026 | $314.44M |
| Net Income | Q3 2026 · Apr 30, 2026 | $337.69M |
| Net Income restated | Q3 2026 · Apr 30, 2025 | $389.74M |
| Net Income restated | Q3 2026 · Apr 30, 2025 | $460.86M |
| Operating Income | Q3 2026 · Apr 30, 2026 | $494.13M |
| Operating Income | Q3 2026 · Apr 30, 2026 | $629.36M |
| Operating Income restated | Q3 2026 · Apr 30, 2025 | $577.77M |
| Operating Income restated | Q3 2026 · Apr 30, 2025 | $759.01M |
| Revenue | Q3 2026 · Apr 30, 2026 | $1.21B |
| Revenue | Q3 2026 · Apr 30, 2026 | $2.56B |
| Revenue | Q3 2026 · Apr 30, 2025 | $1.3B |
| Revenue | Q3 2026 · Apr 30, 2025 | $2.69B |